✦ LIBER ✦

Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer

✍ Scribed by Phillip A. Reece; Irene Stafford; Margaret Davy; Raymond Morris; Susan Freeman

Publisher: Springer
Year: 1989
Tongue: English
Weight: 540 KB
Volume: 24
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00257629

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition of total and free cisplatin

Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer

✍ Charles Erlichman; Steven J. Soldin; Jake J. Thiessen; F. G. Sturgeon; Sheldon F 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 545 KB

Incidence of neuropathy in 395 patients

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin

✍ R. Gerritsen Van Der Hoop; M. E. L. Van Der Burg; W. W. Bokkel Ten Huinink; J. C 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 610 KB

Lack of effect of cisplatin on i. v. L-P

Lack of effect of cisplatin on i. v. L-PAM plasma pharmacokinetics in ovarian cancer patients

✍ M. Zucchetti; M. D'Incalci; Y. Willems; F. Cavalli; C. Sessa 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 268 KB

Melphalan (L-PAM) pharmacokinetics were investigated in nine ovarian cancer patients before and after cisplatin (DDP) treatment. When L-PAM was given 24 h before DDP, the elimination half-life (t 1/2 beta), plasma clearance (Clp), and volume of distribution (Vd beta) of L-PAM were, respectively: 46.

Influence of glutathione administration

Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin

✍ R. Leone; M. E. Fracasso; E. Soresi; G. Cimino; M. Tedeschi; D. Castoldi; V. Mon 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 532 KB

Cisplatin and 5-fluorouracil infusion in

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

✍ Julie A. Kish; Arthur Weaver; John Jacobs; Glenn Cummings; Muhyi Al-Sarraf 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

Topoisomerase-I activity and response to

Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer

✍ Junzo Kigawa; Masakuni Takahashi; Yukihisa Minagawa; Tetsuro Oishi; Toru Sugiyam 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB 👁 2 views

The aim of the present study was to clarify the relationship between topoisomerase-I (topo-I) activity and sensitivity to second-line chemotherapy consisting of cisplatin and camptothecin-11 (CPT-11) in patients with ovarian cancer. Thirty Japanese women with relapsed epithelial ovarian cancer who r